Ron Bose News Today

If approved, the ADC would join sacituzumab govitecan (Trodelvy, Gilead) as agents that target trophoblast cell-surface antigen-2 (Trop-2), which is universally expressed in breast cancer.

Cynthia X. Ma, MD, PhD, discusses updates in triple-negative breast cancer treatment, recent data on HER2-targeted agents in metastatic and early-stage HER2-positive breast cancer, and the role of CDK4/6 inhibitors and oral selective estrogen receptor degraders in hormone receptor–positive disease.

World Health Day: Local man gives thanks to NHS a year on from heart attack April 7 2021, 3.04pm A Fife man has thanked NHS and charity staff to mark World Health Day, a year on from experiencing a heart attack.  Ron Bose, from Rosyth, experienced a heart attack in April last year, just after the country went into lockdown due to the coronavirus pandemic.   The 77-year-old explains: “I thought myself reasonably healthy. I used to go for daily walks and do plenty of exercise.   “I...